Trials / Completed
CompletedNCT01571804
Pregabalin Reduce the Sevoflurane Requirement
Does Pregabalin Reduce the Sevoflurane Requirement During Laparoscopic Cholecystectomy? Mansoura University Hospitals Experience.
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 42 (actual)
- Sponsor
- Mansoura University · Academic / Other
- Sex
- Male
- Age
- 25 Years – 55 Years
- Healthy volunteers
- Not accepted
Summary
Preoperative administration of pregabalin would reduce the end tidal concentration of sevoflurane during laparoscopic cholecystectomy with added beneficial improving of the quality of postoperative analgesia.
Detailed description
laparoscopic cholecystectomy is a painful and stressful surgical procedure. Pregabalin is a lipophilic structural analogue of the inhibitory γ-aminobutyric acid by binding to the presynaptic voltage-gated calcium channels that are widely distributed throughout the central and peripheral nervous system. Pregabalin has anticonvulsant, anxiolytic, sleep-modulating, anti-hyperalgesic, opioid-sparing6 and anti-allodynic properties through inhibition of the release of excitatory neurotransmitters such as glutamate, norepinephrine, serotonin, dopamine and substance P. These unique characteristics make pregabalin as a useful therapeutic for treating neuropathic pain and acute postoperative pain in several models of incisional injury and inflammatory conditions including laparoscopic cholecystectomy.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Placebo | to receive two identical placebo capsules 1 hr before surgery |
| DRUG | pregabalin | one capsule of pregabalin 150 mg and one placebo capsule 1 hr before surgery |
| DRUG | pregabalin | two capsules of pregabalin 150 mg 1 hr before surgery |
Timeline
- Start date
- 2011-12-01
- Primary completion
- 2012-02-01
- Completion
- 2012-03-01
- First posted
- 2012-04-05
- Last updated
- 2012-05-07
Locations
1 site across 1 country: Egypt
Source: ClinicalTrials.gov record NCT01571804. Inclusion in this directory is not an endorsement.